Fascia fibrous compositions and methods for their use and manufacture

US9446077B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9446077-B2
Application numberUS-201414204346-A
CountryUS
Kind codeB2
Filing dateMar 11, 2014
Priority dateMar 13, 2013
Publication dateSep 20, 2016
Grant dateSep 20, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Embodiments of the present invention encompass fascia, fat, and dermis fibrous compositions, and methods for their manufacture and use. In a first aspect, embodiments of the present invention encompass methods for obtaining a fascia fiber for use in producing a biotextile. Exemplary methods may include treating a cadaveric fascia tissue with acetone, and obtaining the fascia fibers from the treated fascia tissue. In some cases, methods may include processing the fascia fibers to produce the fibrous fascia biotextile.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of producing a fibrous fascia biotextile composition, the method comprising: obtaining a deceased donor fascia tissue; treating the deceased donor fascia tissue with acetone; obtaining intact fascia fibers from the treated deceased donor fascia tissue, wherein the intact fascia fibers have a diameter from 5 to 200 microns and a length greater than 20 cm; and processing the intact fascia fibers to produce the fibrous fascia biotextile using a textile or threadmaking process. 2. The method of claim 1 , wherein the method further comprises washing and clearing the deceased donor fascia tissue of biological fluids. 3. The method of claim 1 , wherein the method further comprises exposing the deceased donor fascia tissue to a basic solution and an organic dehydrating solution before treating the deceased donor fascia tissue with acetone. 4. The method of claim 1 , wherein the deceased donor fascia tissue comprises adipose oil and the method further comprises removing substantially all of the adipose oil. 5. The method of claim 1 , wherein processing the intact fascia fibers comprises weaving, bundling, spinning, or carding. 6. The method of claim 1 , wherein the fibrous fascia biotextile comprises sheets, bundles, or other three dimensional fibrous structures. 7. The method of claim 1 , wherein the fibrous fascia biotextile comprises movable fiber configurations. 8. The method of claim 1 , wherein the method further comprises adding a biological component selected from the group consisting of a stem cell composition, a polymer based support, a polymer based skeleton, and a bone construct to the fibrous fascia biotextile. 9. The method of claim 1 , wherein the fibrous fascia biotextile comprises sutures, mats, felts, or pads for use in surgery. 10. The method of claim 1 , wherein the fibrous fascia biotextile comprises gauzes, meshes, implants for use in facial ligament or tendon reconstruction, ligament/tendon bundles, fabric wraps, or fabric clamps. 11. The method of claim 1 , further comprising washing the deceased donor fascia tissue with hexane after treating the deceased donor fascia tissue with acetone. 12. The method of claim 1 , wherein treating the deceased donor fascia tissue with acetone comprises a plurality of washings with acetone. 13. The method of claim 1 , wherein treating the deceased donor fascia tissue with acetone comprises treating the deceased donor tissue with a single organic solvent consisting of acetone. 14. The method of claim 13 , further comprising washing the deceased donor fascia tissue with hexane after treating the deceased donor fascia tissue with acetone. 15. The method of claim 1 , wherein the intact fascia fibers are non-denatured. 16. The method of claim 1 , wherein processing the intact fascia fibers to produce the fibrous fascia biotextile comprises using the textile process. 17. The method of claim 1 , wherein processing the intact fascia fibers to produce the fibrous fascia biotextile comprises using the threadmaking process. 18. The method of claim 1 , wherein processing the intact fascia fibers comprises weaving. 19. The method of claim 1 , wherein processing the intact fascia fibers comprises bundling. 20. The method of claim 1 , wherein processing the intact fascia fibers comprises spinning. 21. The method of claim 1 , wherein processing the intact fascia fibers comprises carding. 22. The method of claim 1 , wherein the fibrous fascia biotextile comprises sheets. 23. The method of claim 1 , wherein the fibrous fascia biotextile comprises bundles. 24. The method of claim 1 , wherein the fibrous fascia biotextile comprises three dimensional fibrous structures. 25. The method of claim 1 , wherein the method further comprises adding a stem cell composition to the fibrous fascia biotextile. 26. The method of claim 1 , wherein the method further comprises adding a polymer based support to the fibrous fascia biotextile. 27. The method of claim 1 , wherein the method further comprises adding a polymer based skeleton to the fibrous fascia biotextile. 28. The method of claim 1 , wherein the method further comprises adding a bone construct to the fibrous fascia biotextile. 29. The method of claim 1 , wherein the fibrous fascia biotextile comprises gauzes. 30. The method of claim 1 , wherein the fibrous fascia biotextile comprises meshes. 31. The method of claim 1 , wherein the fibrous fascia biotextile comprises implants for use in facial ligament or tendon reconstruction. 32. The method of claim 1 , wherein the fibrous fascia biotextile comprises ligament bundles. 33. The method of claim 1 , wherein the fibrous fascia biotextile comprises tendon bundles. 34. The method of claim 1 , wherein the fibrous fascia biotextile comprises fabric wraps. 35. The method of claim 1 , wherein the fibrous fascia biotextile comprises fabric clamps.

Assignees

Inventors

Classifications

  • A61K35/35Primary

    Fat tissue; Adipocytes; Stromal cells; Connective tissues (adipose-derived stem cells A61K35/28; collagen A61K38/39) · CPC title

  • Ligaments, tendons · CPC title

  • Treatment of animal material, e.g. chemical scouring of wool · CPC title

  • characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents · CPC title

  • for soft tissue reconstruction · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9446077B2 cover?
Embodiments of the present invention encompass fascia, fat, and dermis fibrous compositions, and methods for their manufacture and use. In a first aspect, embodiments of the present invention encompass methods for obtaining a fascia fiber for use in producing a biotextile. Exemplary methods may include treating a cadaveric fascia tissue with acetone, and obtaining the fascia fibers from the tre…
Who is the assignee on this patent?
Allosource
What technology area does this patent fall under?
Primary CPC classification A61K35/35. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).